Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BioTel Europe AB
AB
In liquidation
Org 5590706718
Grev Turegatan 78, 114 38
Stockholm
Manufacture of medical and dental instruments and supplies
·
NACE 3250
Est. 2016 · 10 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of medical and dental instruments and supplies
/
BioTel Europe AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
50M
37M
25M
12M
0M
2021: 9M
9M
2021
2022: 19M (+111% vs 2021)
19M
+111%
2022
2023: 36M (+89% vs 2022)
36M
+89%
2023
2024: 40M (+11% vs 2023)
40M
+11%
2024
2025: 28M (-30% vs 2024)
28M
-30%
2025
EBITDA
SEK millions
22M
13M
5M
-4M
-13M
2021: -3M
-3M
2021
2022: -6M (-100% vs 2021)
-6M
-100%
2022
2023: -5M (+17% vs 2022)
-5M
+17%
2023
2024: 15M (+400% vs 2023)
15M
+400%
2024
2025: 2M (-87% vs 2024)
2M
-87%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
27 737
40 344
35 563
19 129
9 284
Staff expenses
−0
356
19
—
—
EBITDA
1 681
14 628
−5 049
−5 971
−3 290
Depreciation & amort.
−715
−1 126
−914
−891
−863
EBIT
967
13 502
−5 963
−6 862
−4 153
Net financials
210
−198
−680
−28
−22
Profit before tax
1 176
13 304
−6 643
−6 890
−4 175
Tax
—
—
—
−0
−0
Net profit
1 176
13 304
−6 643
−6 890
−4 175
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
15 783
14 714
16 075
13 881
3 258
Equity
14 503
13 327
372
265
427
Long-term debt
—
—
—
0
0
Short-term debt
1 281
1 387
15 702
13 507
2 831
Total debt
1 281
1 387
15 702
13 507
2 831
Financial ratios
5-year trend
EBITDA margin
6,1 %
This company
15,8 %
Market median
This company
Market median
61% below market
2021
2025
Equity ratio
91,9 %
This company
38,2 %
Market median
This company
Market median
141% above market
2021
2025
Return on equity
8,1 %
This company
18,4 %
Market median
This company
Market median
56% below market
2021
2025
Net profit margin
4,2 %
This company
8,1 %
Market median
This company
Market median
48% below market
2021
2025
Asset turnover
1,76×
This company
1,12×
Market median
This company
Market median
57% above market
2021
2025
Debt / equity
0,09×
This company
0,62×
Market median
This company
Market median
85% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on BioTel Europe AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
